Cargando…
The severity of airways obstruction as a determinant of treatment response in COPD
Guidelines recommend that patients with COPD are stratified arbitrarily by baseline severity (FEV(1)) to decide when to initiate combination treatment with a long-acting β(2)-agonist and an inhaled corticosteroid. Assessment of baseline FEV(1) as a continuous variable may provide a more reliable pre...
Autores principales: | Calverley, Peter MA, Pauwels, Romain A, Jones, Paul W, Anderson, Julie A, Vestbo, Jørgen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707163/ https://www.ncbi.nlm.nih.gov/pubmed/18046858 |
Ejemplares similares
-
Health status in the TORCH study of COPD: treatment efficacy and other determinants of change
por: Jones, Paul W, et al.
Publicado: (2011) -
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
por: Jenkins, Christine R, et al.
Publicado: (2009) -
Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013) -
Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea
por: Chung, Kyungsoo, et al.
Publicado: (2014) -
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
por: Brook, Robert D, et al.
Publicado: (2017)